The integrin αvβ6 binds and activates latent TGFβ1: A mechanism for regulating pulmonary inflammation and fibrosis

Cell

Volumn 96, Issue 3, 1999, Pages 319-328

  Munger, John S ^c   Huang, Xiaozhu ^a   Kawakatsu, Hisaaki ^a   Griffiths, Mark J D ^a   Dalton, Stephen L ^a,b   Wu, Jianfeng ^a   Pittet, Jean François ^a,b   Kaminski, Naftali ^a   Garat, Chrystelle ^b   Matthay, Michael A ^b   Rifkin, Daniel B ^c   Sheppard, Dean ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; GENE PRODUCT; INTEGRIN; LATENCY ASSOCIATED PEPTIDE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION REGULATION; LUNG FIBROSIS; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033524949     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80545-0     Document Type: Article

References (42)

1. Abe, M., Harpel, J.G., Metz, C.N., Nunes, I., Loskutoff, D.J., and Rifkin, D.B. (1994). An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal. Biochem. 216, 276-284.
2. Barcellos-Hoff, M.H., and Dix, T.A. (1996). Redox-mediated activation of latent transforming growth factor-beta 1. Mol. Endocrinol. 10, 1077-1083.
3. Barcellos-Hoff, M.H., Derynck, R., Tsang, M.L., and Weatherbee, J.A. (1994). Transforming growth factor-beta activation in irradiated murine mammary gland. J. Clin. Invest. 93, 892-899.
4. Barcellos-Hoff, M.H., Ehrhart, E.J., Kalia, M., Jirtle, R., Flanders, K., and Tsang, M.L (1995). Immunohistochemical detection of active transforming growth factor-beta in situ using engineered tissue. Am. J. Pathol. 747, 1228-1237.
5. Border, W.A., Noble, N.A., Yamamoto, Y., Harper, J.R., Yamaguchi, Y., Pierschbacher, M.D., and Ruoslahti, E. (1992). Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 360, 361-364.
6. Breuss, J.M., Gallo, J., DeLisser, H.M., Klimanskaya, I.V., Folkesson, H.G., Pittet, J.F., Nishimura, S.L., Aldape, K., Landers, D.V., Carpenter, W., et al. (1995). Expression of the β6 integrin in development, neoplasia, and tissue repair suggests a role in epithelial remodeling. J. Cell Sci. 708, 2241-2251.
7. Broekelmann, T., Limper, A.H., Colby, T.V., and McDonald, J.A. (1991 ). Transforming growth factor-beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc. Natl. Acad. Sci. USA 88, 6642-6646.
8. Busk, M., Pytela, R., and Sheppard, D. (1992). Characterization of the integrin αvβ6 as a fibronectin-binding protein. J. Biol. Chem. 267, 5790-5796.
9. Cone, R.I., Weinacker, A., Chen, A., and Sheppard, D. (1994). Effects of beta subunit cytoplasmic domain deletions on the recruitment of the integrin alpha v beta 6 to focal contacts. Cell Adhes. Commun. 2, 101-113.
10. Crawford, S.E., Stellmach, V., Murphy-Ullrich, J.E., Ribeiro, S.M., Lawler, J., Hynes, R.O., Boivin, G.P., and Bouck, N. (1998). Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 93, 1159-1170.
11. Dennis, P.A., and Rifkin, D.B. (1991). Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose-6- phosphate/insulin-like growth factor type II receptor. Proc. Natl. Acad. Sci. USA 88, 580-584.
12. Giri, S., Hyde, D.M., and Hollinger, M.A. (1993). Effect of antibody to transforming growth factor-beta on bleomycin induced accumulation of lung collagen in mice. Thorax 48, 959-966.
13. G rainger, D.U., Wakefield, L, Bethell, H.W., Farndale R.W., and Metcalfe, U.C. (1995). Release and activation of platelet latent TGF-beta in blood clots during dissolution with plasmin. Nat. Med. 1, 932-937.
14. Gray, A., and Mason, A. (1990). Requirement for activin A and transforming growth factor-beta 1 pro-region in homodimer assembly. Science 247, 1328-1330.
15. Huang, X.Z., Wu, J.F., Cass, D., Erle, D.J., Corry, D., Young, S.G., Farese, R.V.J., and Sheppard, D. (1996). Inactivation of the integrin beta 6 subunit gene reveals a role of epithelial integrins in regulating inflammation in the lung and skin. J. Cell Biol. 133, 921-928.
16. Huang, X.Z., Wu, J.F., Spong, S., and Sheppard, D. (1998a). The integrin alphavbetae is critical for keratinocyte migration on both its known ligand, fibronectin, and on vitronectin. J. Cell Sci. 111, 2189-2195.
17. Huang, X.Z., Wu, J.F., Zhu, W., Pytela, R., and Sheppard, D. (1998b). Expression of the human integrin betas subunit in alveolar type II cells and bronchiolar epithelial cells reverses lung inflammation in betas knockout mice. Am. J. Respir. Cell. Mol. Biol. 19, 636-642.
18. Kaartinen, V., Voncken, J.W., Shuler, C., Warburton, D., Bu, D. Heisterkamp, N., and Groffen, J. (1995). Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat. Genet. 11, 415-421.
19. Kojima, S., Nara, K., and Rifkin, D.B. (1993). Requirement for transglutaminase in the activation of latent transforming growth factorbeta in bovine endothelial cells. J. Cell Biol. 121, 439-448.
20. Kulkarni, A.B., Huh, C.G., Becker, D., Geiser, A., Lyght, M., Flanders, K.C., Roberts, A.B., Sporn, M.B., Ward, J.M., and Larlsson, S. (1993). Transforming growth factor-beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90, 770-774.
21. Lyons, R.M., Gentry, L.E., Purchio, A.F., and Moses, H.L (1990). Mechanism of activation of latent recombinant transforming growth factor-beta 1 by plasmin. J. Cell Biol. 770, 1361-1367.
22. McMahon, G.A., Dignam, J.D., and Gentry, L.E. (1996). Structural characterization of the latent complex between transforming growth factor beta 1 and beta 1-latency-associated peptide. Biochem. J. 373, 343-351.
23. Meredith, U.E., Jr., Fazeli, B., and Schwartz, M.A. (1993). The extracellular matrix as a cell survival factor. Mol. Biol. Cell 4, 953-961.
24. Munger, U.S., Harpel, J.G., Giancotti, F.G., and Rifkin, D.B. (1998). Interactions between growth factors and integrins: latent forms of transforming growth factor-β are ligands for the integrin αvβ1. Mol. Biol. Cell 9, 2627-2638.
25. Nunes, I., Gleizes, P.E., Metz, C.N., and Rifkin, D.B. (1997). Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta. J. Cell Biol. 736, 1151-1163.
26. Prieto, A.L, Edelman, G.M., and Crossin, K.L. (1993). Multiple integrins mediate cell attachment to cytotactin tenascin. Proc. Natl. Acad. Sci. USA 90, 10154-10158.
27. Pytela, R., Pierschbacher, M.D., and Ruoslahti, E. (1985). Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor. Cell 40, 191-198.
28. Sanford, L.P., Ormsby, I., Gittenberger-de Groot, A.C., Sariola, H., Friedman, R., Boivin, G.P., Cardell, E.L., and Doetschman, T. (1997). TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 724, 2659-2670.
29. Sato, Y., Tsuboi, R., Moses, H., and Rifkin, D.B. (1990). Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J. Cell Biol. 111, 757-763.
30. Schultz-Cherry, S., and Murphy-Ullrich, J.E. (1993). Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. J. Cell Biol. 722, 923-932.
31. Schultz-Cherry, S., Lawler, J., and Murphy-Ullrich, J.E. (1994). The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta. J. Biol. Chem. 269, 26783-26788.
32. Schultz-Cherry, S., Chen, H., Mosher, D.F., Misenheimer, T.M., Krutzsch, H.C., Roberts, D.D., and Murphy-Ullrich, J.E. (1995). Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1. J. Biol. Chem. 270, 7304-7310.
33. Sheppard, D., Cohen, D.S., Wang, A., and Busk, M. (1992). Transforming growth factor beta differentially regulates expression of integrin subunits in guinea pig airway epithelial cells. J. Biol. Chem. 267, 17409-17414.
34. Shull, M.M., Ormsby, I., Kier, A.B., Pawlowski, S., Diebold, R.J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin D., et al. (1992). Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359, 693-699.
35. Sime, P.J., Xing, Z., Graham, F.L, Csaky K.G., and Gauldie, J. (1997). Adenovector-mediated gene transfer of active transforming growth factor-β1 induces prolonged severe fibrosis in rat lung. J. Clin. Invest. 100, 768-776.
36. Taipale, J., Saharinen, J., Hedman K., and Keski-Oja, J. (1996). Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils. J. Histochem. Cytochem. 44, 875-889.
37. Taipale, J., Saharinen, J., and Keski-Oja, J. (1998). Extracellular matrix-associated transforming growth factor-beta: role in cancer cell growth and invasion. Adv. Cancer. Res. 75, 87-134.
38. Van Obberghen-Schilling, E., Roche, N.S., Flanders, K.C, Sporn, M.B., and Roberts, A.B. (1988). Transforming growth factor-betal positively regulates its own expression in normal and transformed cells. J. Biol. Chem. 263, 7741-7746.
39. Wang, A., Yokosaki, Y., Ferrando, R., Balmes, J., and Sheppard, D. (1996). Differential regulation of airway epithelial integrins by growth factors. Am. J. Respir. Cell. Mol. Biol. 15, 664-672.
40. Weinacker, A., Chen, A., Agrez, M., Cone, R.I., Nishimura, S., Wayner, E., Pytela, R., and Sheppard, D. (1994). Role of the integrin alphaVbeta6 in cell attachment to fibronectin. Heterologous expression of intact and secreted forms of the receptor. J. Biol. Chem. 269, 6940-6948.
41. Werb, Z., Tremble, P.M., Behrendtsen, O., Crowley, E., and Damsky, C.H. (1989). Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J. Cell. Biol. 109, 877-889.
42. Woessner, J.F. (1961 ). The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch. Biochem. Biophys. 93, 440-447.